Application of recombinant hemagglutinin proteins as alternative antigen standards for pandemic influenza vaccines

摘要

The single radial immunodiffusion (SRID) assay, used to quantify hemagglutinin (HA) in influenza vaccines, requires reference reagents; however, because centralized production of reference reagents may slow the emergency deployment of vaccines, alternatives are needed.